Literature DB >> 18592824

Characterization of the duration from onset of asthma symptoms to asthma disease.

Molly Martyn1, Amy L Weaver, Robert M Jacobson, Young J Juhn.   

Abstract

BACKGROUND: Little is known about factors associated with progression of childhood asthma from onset of symptoms to index date determined by medical records.
OBJECTIVE: To determine the duration between the onset of asthma symptoms to index date of asthma (ie, time when one met the criteria for asthma) and associated factors.
METHODS: Study participants came from a sample of 839 healthy children, aged 5 to 12 years, who had participated in a previous study. Comprehensive medical record reviews were conducted to determine first documentation of asthma symptoms and index date of asthma. Factors were evaluated for an association with the duration from onset of asthma symptoms to index date of asthma.
RESULTS: Of the study sample, 222 children met the criteria for asthma and had an available onset date of asthma symptoms. The median ages at onset of asthma symptoms and the index date were 5.6 and 7.6 years, respectively. The median duration between onset of asthma symptoms and index date was 2.9 months, and the mean was 17.2 months. There was a tendency for patients with a pet at home (P = .047), exercise-induced symptoms (P = .04), younger age at symptom onset (P = .05), and more severe asthma (P = .05) to have a shorter duration from onset of symptoms to index date.
CONCLUSIONS: The duration from onset of asthma symptoms to index date of asthma varies significantly depending on host and environmental factors. It does not necessarily correlate with commonly recognized risk factors for incidence or severity of asthma.

Entities:  

Mesh:

Year:  2008        PMID: 18592824     DOI: 10.1016/S1081-1206(10)60059-2

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  3 in total

1.  Impact of delay in asthma diagnosis on health care service use.

Authors:  Brian A Lynch; Chelsey A Van Norman; Robert M Jacobson; Amy L Weaver; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2010 Jul-Aug       Impact factor: 2.587

2.  Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Authors:  W Gerald Teague; Brenda R Phillips; John V Fahy; Sally E Wenzel; Anne M Fitzpatrick; Wendy C Moore; Annette T Hastie; Eugene R Bleecker; Deborah A Meyers; Stephen P Peters; Mario Castro; Andrea M Coverstone; Leonard B Bacharier; Ngoc P Ly; Michael C Peters; Loren C Denlinger; Sima Ramratnam; Ronald L Sorkness; Benjamin M Gaston; Serpil C Erzurum; Suzy A A Comhair; Ross E Myers; Joe Zein; Mark D DeBoer; Anne-Marie Irani; Elliot Israel; Bruce Levy; Juan Carlos Cardet; Wanda Phipatanakul; Jonathan M Gaffin; Fernando Holguin; Merritt L Fajt; Shean J Aujla; David T Mauger; Nizar N Jarjour
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-31

3.  Operational definitions of paediatric asthma used in epidemiological studies: A systematic review.

Authors:  Mohammad Shahidul Islam; Samin Huq; Salahuddin Ahmed; Sudipto Roy; Jürgen Schwarze; Aziz Sheikh; Samir K Saha; Steve Cunningham; Harish Nair
Journal:  J Glob Health       Date:  2021-07-17       Impact factor: 4.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.